₹300
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Glycobreez-I HMPC DPI Capsule 10's is indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining).
Glycobreez-I HMPC DPI Capsule 10's is a combination of two medicines, namely: Indacaterol and Glycopyrronium. Indacaterol relaxes and widens the openings in the airways, making it easier to breathe. Glycopyrronium decreases the secretions in the airways. Together, Glycobreez-I HMPC DPI Capsule 10's provides relief from COPD.
In some cases, you may experience certain common side effects such as upper respiratory tract infection, inflammation of the sinuses, runny/stuffy nose, headache, dizziness, and stomach upset. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not stop taking Glycobreez-I HMPC DPI Capsule 10's on your own, as it might cause worsening of symptoms. Consult your doctor before taking Glycobreez-I HMPC DPI Capsule 10's if you are pregnant or breastfeeding. Glycobreez-I HMPC DPI Capsule 10's may cause dizziness, so drive with caution. Avoid consuming alcohol, as it might cause increased dizziness.
Glycobreez-I HMPC DPI Capsule 10's is not recommended for children below 18 years, as the safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid any interactions.
Glycobreez-I HMPC DPI Capsule 10's is used to manage chronic respiratory conditions. The detailed uses of Glycobreez-I HMPC DPI Capsule 10's include:
Unsafe
You are recommended to avoid alcohol consumption while taking Glycobreez-I HMPC DPI Capsule 10's as it might increase side effects like dizziness, drowsiness or impaired coordination.
Consult your doctor
Please consult your doctor if are pregnant or planning pregnancy before using Glycobreez-I HMPC DPI Capsule 10's.
Consult your doctor
Please consult your doctor if are a breastfeeding mother before using Glycobreez-I HMPC DPI Capsule 10's.
Caution
Glycobreez-I HMPC DPI Capsule 10's may cause dizziness. Drive or operate machinery only if you are alert.
Caution
Dose adjustment may be needed. Please consult your doctor if you have liver impairment/liver disease or any concerns regarding this.
Caution
Dose adjustment may be needed. Please consult your doctor if you have kidney impairment/kidney disease or any concerns regarding this.
Unsafe
Glycobreez-I HMPC DPI Capsule 10's is not recommended for children and adolescents below 18 years as safety and effectiveness have not been established.
Consult your doctor
If you have any heart problems, inform your doctor. Glycobreez-I HMPC DPI Capsule 10's may cause fast or irregular heartbeat in some patients.
Safe if prescribed
Glycobreez-I HMPC DPI Capsule 10's may be used by elderly patients if prescribed by a doctor.

Have a query?
Drug-Drug Interactions: Glycobreez-I HMPC DPI Capsule 10's may interact with beta-blocker (propranolol, timolol), steroid (prednisolone), diuretic (hydrochlorothiazide), anti-asthma (theophylline).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have narrow-angle glaucoma, difficulty in urination, heart/liver/kidney problems, seizures, gastrointestinal obstruction, hypertension, myasthenia gravis, or infectious diarrhoea.
Login/Sign Up
Login/Sign Up
RXZydus Healthcare Ltd
₹421.5
(₹14.05 per unit)
RXLupin Ltd
₹1076
(₹35.87/ 1gm)
Glycobreez-I HMPC DPI Capsule 10's is used to treat Chronic Obstructive Pulmonary Disease (COPD).
Glycobreez-I HMPC DPI Capsule 10's contains Indacaterol and Glycopyrronium. Indacaterol relaxes and widens the airway openings, making it easier for air to enter and exit the lungs. Glycopyrronium decreases the secretions in the airways. Together, Glycobreez-I HMPC DPI Capsule 10's provides relief from COPD.
Glycobreez-I HMPC DPI Capsule 10's is indicated as an ongoing treatment for COPD. It does not treat a sudden attack of wheezing or breathlessness. Use a rescue inhaler to treat sudden breathing problems.
Dry mouth could be a side-effect of Glycobreez-I HMPC DPI Capsule 10's. Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol; drinking water regularly and chewing sugar-free gum/candy might help in stimulating saliva and thereby prevents drying of the mouth.
Do not stop using Glycobreez-I HMPC DPI Capsule 10's on your own as it might cause worsening of symptoms. To treat your condition effectually, continue using Glycobreez-I HMPC DPI Capsule 10's for as long as your doctor has prescribed it. Talk to your doctor if your breathing problems, wheezing, or cough do not improve or worsen.
No, Glycobreez-I HMPC DPI Capsule 10's is not indicated for the treatment of asthma as the safety and effectiveness of Glycobreez-I HMPC DPI Capsule 10's in patients with asthma have not been established. Consult your doctor if you have asthma.
Disclaimer
We provide you with authentic, trustworthy and relevant information